Navigation Links
Abuse in Medical Technology
... tragedies, of prescription chemical addiction and abuse are being discussed, these articles offer crucial ... direction and optimism.
Addiction to and abuse of prescription opioid drugs are prevalent, and ... have the greatest risk of opioid dependence and abuse among health care providers. Also in the ...
... therapies.(2,3A) However, prescription opioid abuse has escalated along with increased legitimate use ... relief while minimizing the potential for misuse, abuse and diversion.(3B,7) Study Design The ... 3. Woolf CJ, Hashmi M. Use and abuse of opioid analgesics: potential methods to ...
... that affects the central nervous system. abuse of the drug leads to devastating ... treatment for methamphetamine and other stimulant abuse in 2006. In addition, according to the 2006 ... National Drug Control Policy, the costs of drug abuse to society were an estimated $180 billion in 2002 ...
... clinically relevant features addressing abuse liability alongside a promising safety and ... of ALO-01 when crushed -- a common method of abuse -- among recreational drug users and when taken ... "The undertreatment of chronic pain and the abuse of prescription opioids are both serious health ...
... and a Schedule II controlled substance, with an abuse liability similar to other opioid analgesics. ... is concerned about an increased risk of misuse, abuse or diversion. Schedule II opioid substances which ... and methadone have the highest potential for abuse and risk of fatal overdose due to respiratory ...
... Institute, Philadelphia, PA, Associate Director, Center for Substance abuse Research, University of Maryland, College Park , MD. One of Dr. Arria's ... Institute, Philadelphia, PA Associate Director, Center for Substance abuse Research, University of Maryland, College Park , MD Christina ...
... triple-action combination of niacin and inactive ingredients reduces its abuse liability. About EMBEDA(TM) EMBEDA(TM) is an investigational ... and there is no evidence that the naltrexone in EMBEDA(TM) reduces the abuse liability of EMBEDA(TM). About King Pharmaceuticals, Inc. King, ...
... similar to smoking marijuana, leading researchers to conclude the abuse potential of this class should be studied further. Using the Addiction Research Center Inventory (ARCI), the gold-standard for determining the abuse liability of substances, Dr. Wasan and colleagues at McLean Hospital ...
... and brain to effectively treat pain, including medications with decreased abuse potential." At this year's meeting, attendees will have access to ... Trauma/Combat Injury, Poster 273 Reduction of Opioid/Illicit Drug abuse & Electronic Prescription Monitoring, Poster 274 About ...
... patients progress faster in physical therapy to how people in substance abuse treatment can practice skills and behaviors in the virtual world of a game ... designed to enable people aged 18 to 65 that are diagnosed with alcohol abuse or dependence to practice skills that can help them prevent real-world ...
... the national data on this growing public health problem -- the Substance abuse and Mental Health Services Administration (SAMHSA) reports that ... respiratory depression and death. SUBOXONE has potential for abuse and produces dependence of the opioid type with a milder withdrawal ...
... first and only prescription sleep medication that has shown no evidence of abuse or dependence in clinical studies,* and has not been designated as a ... the sleep- wake cycle. *ROZEREM is not a controlled substance. A clinical abuse liability study showed no differences indicative of abuse potential ...
... of guanfacine, designed to provide steady delivery of drug throughout the day. INTUNIV is not a controlled substance and has no known potential for abuse or dependence. Guanfacine, the active ingredient in INTUNIV, is thought to work directly by binding selectively to alpha-2A adrenergic ...
... diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. ...
... is concerned about an increased risk of misuse and abuse. All patients treated with mu-opioid agonists require careful monitoring for signs of abuse and addition. NUCYNTA(TM) may be abused by crushing, chewing, snorting or injecting the product. These practices pose a significant risk to the ...
... Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse or Adderall XR. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
... clinical trials, INTUNIV demonstrated significant reduction in ADHD symptoms. INTUNIV is not a controlled substance and has no known mechanism for abuse or dependence. Guanfacine, the active ingredient in INTUNIV, is thought to work directly by binding selectively to alpha-2A adrenergic receptors ...
... are exciting for researchers in the field of pain medicine, doctors whom treat pain, and patients who suffer or are under-treated because of the abuse potential and side effects associated with opioid treatments," said Colin Goodchild, PhD, and director of the Centre for Pain Research and Palliative ...
... in multiple species. In contrast to currently marketed opioids, CR845 did not produce inhibition of intestinal transit (ileus) or elicit signs of abuse or addiction liability in animal models. Preclinical studies also indicate that CR845 possesses anti-itch activity. About Cara Therapeutics ...
... or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
... or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
... prescribed FENTORA are opioid-tolerant. Additionally, the company will continue to enhance its existing programs to mitigate risks associated with abuse and misuse. FENTORA is currently approved for the management of breakthrough pain in opioid-tolerant patients with cancer (for full prescribing ...
... diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information about Inverness Medical Innovations, please ...
... proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit ...
Acura and King Receive FDA Complete Response Letter Regarding Acurox(R)
... Letter raises issues regarding the potential abuse deterrent benefits of Acurox(R). Acura and King ... Technology, which is designed to deter misuse and abuse by intentional swallowing of excess quantities of ... product candidates and other innovative abuse deterrent technologies. Acura and King jointly ...Classwide Opioids REMS: A Good Idea, Implement Carefully
... patients and non-patients, those who misuse or abuse the drug and are not prescribed the medication. ... Will drug abusers shift their abuse to other licit or illicit substances? ... chronic pain in the effort to prevent misuse and abuse of these important medications. It would be of ...American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'
... Broken Bones as Indicators of Child abuse ( ... Seen Between Types of Orthopaedic Injury and abuse In a study of nearly 1,500 ... classified as either confirmed victims of child abuse or sufferers of accidental trauma, clear ...FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain
... increased risk of misuse, abuse, or diversion. abuse of tapentadol poses a risk of overdose and death. This risk is increased with concurrent abuse of tapentadol with alcohol and other substances. Monitor patients closely for signs of abuse and addiction. Tapentadol may impair ...... therapies.(2,3A) However, prescription opioid abuse has escalated along with increased legitimate use ... relief while minimizing the potential for misuse, abuse and diversion.(3B,7) Study Design The ... 3. Woolf CJ, Hashmi M. Use and abuse of opioid analgesics: potential methods to ...
REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
... E. Brown, DVM, President and CEO of DURECT. "The abuse of pain medications is a widespread problem in ... with the added benefit of being less prone to abuse (e.g. by crushing or water extraction) than other ... superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, ...... that affects the central nervous system. abuse of the drug leads to devastating ... treatment for methamphetamine and other stimulant abuse in 2006. In addition, according to the 2006 ... National Drug Control Policy, the costs of drug abuse to society were an estimated $180 billion in 2002 ...
... clinically relevant features addressing abuse liability alongside a promising safety and ... of ALO-01 when crushed -- a common method of abuse -- among recreational drug users and when taken ... "The undertreatment of chronic pain and the abuse of prescription opioids are both serious health ...
... and a Schedule II controlled substance, with an abuse liability similar to other opioid analgesics. ... is concerned about an increased risk of misuse, abuse or diversion. Schedule II opioid substances which ... and methadone have the highest potential for abuse and risk of fatal overdose due to respiratory ...
... Institute, Philadelphia, PA, Associate Director, Center for Substance abuse Research, University of Maryland, College Park , MD. One of Dr. Arria's ... Institute, Philadelphia, PA Associate Director, Center for Substance abuse Research, University of Maryland, College Park , MD Christina ...
... triple-action combination of niacin and inactive ingredients reduces its abuse liability. About EMBEDA(TM) EMBEDA(TM) is an investigational ... and there is no evidence that the naltrexone in EMBEDA(TM) reduces the abuse liability of EMBEDA(TM). About King Pharmaceuticals, Inc. King, ...
... similar to smoking marijuana, leading researchers to conclude the abuse potential of this class should be studied further. Using the Addiction Research Center Inventory (ARCI), the gold-standard for determining the abuse liability of substances, Dr. Wasan and colleagues at McLean Hospital ...
... and brain to effectively treat pain, including medications with decreased abuse potential." At this year's meeting, attendees will have access to ... Trauma/Combat Injury, Poster 273 Reduction of Opioid/Illicit Drug abuse & Electronic Prescription Monitoring, Poster 274 About ...
Novel Compound Shows Promise for Treatment of Alcoholism
... for the treatment of alcoholism. The National Institute on Alcohol abuse and Alcoholism (NIAAA) estimates 15.1 million people are alcohol-abusing ... by the State of California for Medical Research on Alcohol and Substance abuse and Department of Defense. Southern Research operates a successful drug ...... patients progress faster in physical therapy to how people in substance abuse treatment can practice skills and behaviors in the virtual world of a game ... designed to enable people aged 18 to 65 that are diagnosed with alcohol abuse or dependence to practice skills that can help them prevent real-world ...
... the national data on this growing public health problem -- the Substance abuse and Mental Health Services Administration (SAMHSA) reports that ... respiratory depression and death. SUBOXONE has potential for abuse and produces dependence of the opioid type with a milder withdrawal ...
Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
... smoking cessation researchers and the National Institute on Drug abuse (NIDA). Nabi will use these validated and promising nine-month data to ... that it received a $4.1 million grant from the National Institute on Drug abuse (NIDA), which is part of the National Institutes of Health. NIDA has also ...... first and only prescription sleep medication that has shown no evidence of abuse or dependence in clinical studies,* and has not been designated as a ... the sleep- wake cycle. *ROZEREM is not a controlled substance. A clinical abuse liability study showed no differences indicative of abuse potential ...
GAA Calls on Secretary Clinton to Speak Out Against Gender-Based Violence During Her Africa Trip
... African governments to address the scourge of violence," said Zeitz. Worldwide, one in three women will survive physical, sexual, or emotional abuse in her lifetime. One in five will survive rape or attempted rape, and around 50% of female sexual assault survivors are 15 years or younger at the ...... of guanfacine, designed to provide steady delivery of drug throughout the day. INTUNIV is not a controlled substance and has no known potential for abuse or dependence. Guanfacine, the active ingredient in INTUNIV, is thought to work directly by binding selectively to alpha-2A adrenergic ...
PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it
... veterans without PTSD (HR = 1.8, 95% CI 1.7-1.9). Results were similar when they excluded those with a history of traumatic brain injury, substance abuse or depression. "It is critical to follow patients with PTSD, and evaluate them early for dementia," Yaffe said. "Further research is needed ...Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
... and can be caused by many different conditions or "insults" to the liver including Hepatitis C and other viral infections, obesity, chronic alcohol abuse or autoimmune diseases. Conatus was founded by the executive management team of Idun Pharmaceuticals in July 2005 following the successful sale of ...... diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. ...
... is concerned about an increased risk of misuse and abuse. All patients treated with mu-opioid agonists require careful monitoring for signs of abuse and addition. NUCYNTA(TM) may be abused by crushing, chewing, snorting or injecting the product. These practices pose a significant risk to the ...
... Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse or Adderall XR. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
... clinical trials, INTUNIV demonstrated significant reduction in ADHD symptoms. INTUNIV is not a controlled substance and has no known mechanism for abuse or dependence. Guanfacine, the active ingredient in INTUNIV, is thought to work directly by binding selectively to alpha-2A adrenergic receptors ...
One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials
... leading to Wentland's latest discovery was funded in 1999 through a $826,000 grant from the National Institutes of Health/National Institute on Drug abuse (NIH-NIDA) in an effort to discover novel drugs to treat cocaine abuse. In 2002, Wentland's NIH grant was renewed for an additional $1.6 million, and ...DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
... oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit ...Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
... or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...Premier Research Announces Milestone New Drug Application
... relief of moderate to severe pain. Acurox(R) utilizes Acura Pharmaceuticals' patented Aversion(R) Technology, which is designed to deter misuse and abuse by intentional swallowing of excess quantities of tablets, intravenous injection of dissolved tablets and nasal snorting of crushed tablets. ...... are exciting for researchers in the field of pain medicine, doctors whom treat pain, and patients who suffer or are under-treated because of the abuse potential and side effects associated with opioid treatments," said Colin Goodchild, PhD, and director of the Centre for Pain Research and Palliative ...
... in multiple species. In contrast to currently marketed opioids, CR845 did not produce inhibition of intestinal transit (ileus) or elicit signs of abuse or addiction liability in animal models. Preclinical studies also indicate that CR845 possesses anti-itch activity. About Cara Therapeutics ...
... or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
... diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information about Inverness Medical Innovations, please ...... or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse. abuse of amphetamines may lead to dependence. Misuse of amphetamine may cause sudden death and serious cardiovascular adverse events. These events have ...
... prescribed FENTORA are opioid-tolerant. Additionally, the company will continue to enhance its existing programs to mitigate risks associated with abuse and misuse. FENTORA is currently approved for the management of breakthrough pain in opioid-tolerant patients with cancer (for full prescribing ...
Pediatric Heart Transplants at Montefiore Approved by NY State Department of Health
... a key provider of community-based care through its network of 16 school-based clinics, the Child Advocacy Center for diagnosis and treatment of child abuse and neglect, a Safe House for lead poison prevention, mobile pediatric centers and other unique initiatives. ...... diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts. For more information about Inverness Medical Innovations, please ...
... proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs. For more information, please visit ...
Other ContentsOther Tags
(Date:5/16/2013)... our pulses outside of the gym. But doctors use the ... , Zhenan Bao, a professor of chemical engineering at Stanford, ... and no wider than a postage stamp. The flexible skin-like ... sensitive enough to help doctors detect stiff arteries and cardiovascular ... continuously track heart health and provide doctors a safer method ...
(Date:5/16/2013)... , May 16, 2013 The ... Award on Tuesday to Germany,s ... biometric border control system. DERMALOG has been ... Best Practices Award in the category Global Biometrics and ... edge Biometric Border Control System . One ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2(Date:5/20/2013)... May 20, 2013 Healing Heart Urgent ... newest office on Briarcliff Road in the Druid Hills ... facility includes Dr. Fidias E. De León M.D. and ... will provide extensive medical services, occupational health, chiropractic care ... Atlanta metropolitan area. They also offer a full range ...
(Date:5/20/2013)... 20, 2013 AURORA, Colo. – May ... accredited university, has developed a Bachelor of Science ... how they feel about continuing their education and gauge ... out the complimentary worksheet, respond to ten statements and ... rate on a BSN-readiness scale. , New industry standards ...
(Date:5/20/2013)... NY (PRWEB) May 20, 2013 InVite® ... City, today announced the introduction of its new ... that provides high density nutrition with plant extracts from ... herbs, spices, royal jelly, apple pectin, plant enzymes and ... offers the micronutrients and antioxidant levels of several servings ...
(Date:5/20/2013)... Can you tell a joke well? , Do people roll their ... like to be funnier as a speaker, teacher, presenter of any ... missing? , Can't think of a snappy comeback when someone hits ... like you, don't worry. Help is here. I believe ... even learn to tell a joke well. I am not kidding. ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...
Breaking Medicine News(10 mins):Health News:Healing Heart Urgent Care Opens New Office In Atlanta 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 2Health News:InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™ 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3[0] Healing Heart Urgent Care Opens New Office In Atlanta[0] American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness[0] InVite® Health Introduces New Food-Based Dietary Supplement – Greens Hx™[0] Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke[0] FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays
KirinExportTaintedToothDisadvantagedExcavationsPandemicAssaultsCoronerViscosityPredictorVisuallyMexicoDysfunctional
Other Tags| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |